| NCT ID | NCT05866523 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Loma Linda University |
| Condition | HIV Infections |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-10-16 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2023-10-16 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Exploring the effect of team-based ARTAS intervention in an inpatient setting on HIV linkage to care and hospital readmission rates.
Eligibility Criteria
Inclusion Criteria: * 18 years of age or greater * newly diagnosed HIV * Known diagnosis of HIV not on ART within 30 days of admission * Known HIV and not virally suppressed based on interview * Known HIV and has not been under the care of an HIV specialist within the past 6 months Exclusion Criteria: * All three criteria must be present for exclusion: * virally suppressed * actively taking ART * are under active care of an HIV specialist within the last 6 months * Less than 18 years of age (stand alone exclusion)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05866523 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying HIV Infections. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05866523 currently recruiting?
Yes, NCT05866523 is actively recruiting participants. Contact the research team at jveltman@llu.edu for enrollment information.
Where is the NCT05866523 trial being conducted?
This trial is being conducted at Loma Linda, United States.
Who is sponsoring the NCT05866523 clinical trial?
NCT05866523 is sponsored by Loma Linda University. The trial plans to enroll 250 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.